Malta - English - Medicines Authority

mylan pharmaceuticals limited damastown industrial park mulhuddart dublin15 dublin, ireland - piperacillin, tazobactam - powder for solution for infusion or injection - piperacillin 2 g tazobactam 0.25 g - antibacterials for systemic use

Malta - English - Medicines Authority

mylan pharmaceuticals limited damastown industrial park mulhuddart dublin15 dublin, ireland - piperacillin, tazobactam - powder for solution for infusion - piperacillin 4 g tazobactam 0.5 g - antibacterials for systemic use

New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - piperacillin sodium 2.085 g equivalent to piperacillin 2g; tazobactam sodium 0.2683 g equivalent to tazobactam 0.25g - powder for injection - active: piperacillin sodium 2.085 g equivalent to piperacillin 2g tazobactam sodium 0.2683 g equivalent to tazobactam 0.25g - piperacillin/ tazobactam is indicated for the treatment of the following systemic and/or local bacterial infections in which susceptible organisms have been detected or are suspected: 1. lower respiratory tract infections 2. urinary tract infections (complicated and uncomplicated) 3. intra-abdominal infections 4. skin and skin structure infections 5. bacterial septicaemia 6. gynaecological infections 7. bacterial infections in neutropenic patients. full therapeutic doses of piperacillin/ tazobactam kabi plus an aminoglycoside should be used. 8. bone and joint infections 9. polymicrobic infections: piperacillin/tazobactam kabi is indicated for polymicrobic infections including those where aerobic and anaerobic organisms are suspected (intra-abdominal, skin and skin structure, upper and lower respiratory tract, gynaecological). children under the age of 12 years: in hospitalised children aged 2 to 12 years, piperacillin/ tazobactam is indicated for the treatment of serious intra-abdominal infections.

New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - piperacillin sodium 4.17 g equivalent to piperacillin 4g; tazobactam sodium 0.5366 g equivalent to tazobactam 0.5g - powder for injection - active: piperacillin sodium 4.17 g equivalent to piperacillin 4g tazobactam sodium 0.5366 g equivalent to tazobactam 0.5g - piperacillin/ tazobactam is indicated for the treatment of the following systemic and/or local bacterial infections in which susceptible organisms have been detected or are suspected: 1. lower respiratory tract infections 2. urinary tract infections (complicated and uncomplicated) 3. intra-abdominal infections 4. skin and skin structure infections 5. bacterial septicaemia 6. gynaecological infections 7. bacterial infections in neutropenic patients. full therapeutic doses of piperacillin/ tazobactam kabi plus an aminoglycoside should be used. 8. bone and joint infections 9. polymicrobic infections: piperacillin/tazobactam kabi is indicated for polymicrobic infections including those where aerobic and anaerobic organisms are suspected (intra-abdominal, skin and skin structure, upper and lower respiratory tract, gynaecological). children under the age of 12 years: in hospitalised children aged 2 to 12 years, piperacillin/ tazobactam is indicated for the treatment of serious intra-abdominal infections.

Ireland - English - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - piperacillin; tazobactam - powder for solution for infusion - piperacillin and enzyme inhibitor

Ireland - English - HPRA (Health Products Regulatory Authority)

generics (uk) limited - piperacillin sodium; tazobactam (as sodium salt) - powder for solution for infusion - 4/0.5 gram(s) - combinations of penicillins, incl. beta-lactamase inhibitors; piperacillin and enzyme inhibitor

Ireland - English - HPRA (Health Products Regulatory Authority)

generics (uk) limited - piperacillin sodium; tazobactam (as sodium salt) - powder for solution for infusion - 2/0.25 gram(s) - combinations of penicillins, incl. beta-lactamase inhibitors; piperacillin and enzyme inhibitor

Ireland - English - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd., t/a gerard laboratories - piperacillin sodium; tazobactam (as sodium salt) - powder for solution for infusion - 2/0.25 gram(s) - combinations of penicillins, incl. beta-lactamase inhibitors; piperacillin and enzyme inhibitor

Ireland - English - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd., t/a gerard laboratories - piperacillin sodium; tazobactam (as sodium salt) - powder for solution for infusion - 4/0.5 gram(s) - combinations of penicillins, incl. beta-lactamase inhibitors; piperacillin and enzyme inhibitor

Ireland - English - HPRA (Health Products Regulatory Authority)

viatris limited - piperacillin sodium; tazobactam (as sodium salt) - powder for solution for infusion - combinations of penicillins, incl. beta-lactamase inhibitors; piperacillin and enzyme inhibitor